GlassScriptPhysician profile
David G Lichter
NPI 1265408934
$121,001.39
in general payments reported to CMS, 2019-2025
14 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48K · 2020: $17K · 2021: $21K · 2022: $24K · 2023: $10K · 2024: $24.62 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,023.50 |
| Food and Beverage | $205.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $74,046.06 | 2019-2023 | Austedo, Austedo Xr |
| Acorda Therapeutics, INC | $29,124.89 | 2019-2020 | |
| Kyowa Kirin, INC. | $14,802.35 | 2020-2022 | |
| Amneal Pharmaceuticals LLC | $2,700.00 | 2020 | |
| Mdd US Operations, LLC | $96.80 | 2024-2025 | Gocovri |
| Abbott Laboratories | $82.47 | 2019-2023 | Infinity |
| Medtronic, INC. | $29.00 | 2021 | |
| Eisai INC. | $23.83 | 2025 | |
| Amgen INC. | $20.26 | 2025 | Uplizna |
| Abbvie INC. | $17.55 | 2023 | |
| Almatica Pharma LLC | $15.94 | 2022 | |
| Sunovion Pharmaceuticals INC. | $15.81 | 2020 | |
| Impel Pharmaceuticals INC. | $15.32 | 2022 | |
| Lundbeck LLC | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lichter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.